Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia

Clinical Nutrition

Volumn 31, Issue 5, 2012, Pages 765-773

  Winter, Aaron ^a   MacAdams, Jacqueline ^a   Chevalier, Stéphanie ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cachexia; Glucose kinetics; Hyperinsulinemic clamp; Insulin resistance; Lung cancer; Protein metabolism

Indexed keywords

ADULT; ADVANCED CANCER; AMINOACIDEMIA; ARTICLE; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LUNG NON SMALL CELL CANCER; MALE; MUSCLE ATROPHY; PROTEIN DEGRADATION; PROTEIN HOMEOSTASIS; PROTEIN SYNTHESIS; WEIGHT REDUCTION;

AGED; AMINO ACIDS; BODY MASS INDEX; CACHEXIA; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; KINETICS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PROTEIN BIOSYNTHESIS; PROTEINS;

EID: 84866603218     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.05.003     Document Type: Article

References (67)

1. Evans W.J., Morley J.E., Argiles J., Bales C., Baracos V., Guttridge D., et al. Cachexia: a new definition. Clin Nutr Dec 2008, 27(6):793-799.
2. Antoun S., Birdsell L., Sawyer M.B., Venner P., Escudier B., Baracos V.E. Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. J Clin Oncol Feb 20;2010, 28(6):1054-1060.
3. Deans C., Wigmore S.J. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care May 2005, 8(3):265-269.
4. Prado C.M., Baracos V.E., McCargar L.J., Reiman T., Mourtzakis M., Tonkin K., et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res Apr 15 2009, 15(8):2920-2926.
5. Prado C.M., Baracos V.E., McCargar L.J., Mourtzakis M., Mulder K.E., Reiman T., et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res Jun 1 2007, 13(11):3264-3268.
6. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ Nov 8 1997, 315(7117):1219-1222.
7. Muscaritoli M., Anker S.D., Argiles J., Aversa Z., Bauer J.M., Biolo G., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" Clin Nutr (Edinburgh, Scotland) Apr 2010, 29(2):154-159.
8. Cersosimo E., Pisters P.W., Pesola G., Rogatko A., Vydelingum N.A., Bajorunas D., et al. The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia. Surgery Apr 1991, 109(4):459-467.
9. Makino T., Noguchi Y., Yoshikawa T., Doi C., Nomura K. Circulating interleukin 6 concentrations and insulin resistance in patients with cancer. Br J Surg Dec 1998, 85(12):1658-1662.
10. Copeland G.P., Leinster S.J., Davis J.C., Hipkin L.J. Insulin resistance in patients with colorectal cancer. Br J Surg Nov 1987, 74(11):1031-1035.
11. Chevalier S., Marliss E.B., Morais J.A., Lamarche M., Gougeon R. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr Aug 2005, 82(2):355-365.
12. Chevalier S., Gougeon R., Choong N., Lamarche M., Morais J.A. Influence of adiposity in the blunted whole-body protein anabolic response to insulin with aging. J Gerontol A Biol Sci Med Sci Feb 2006, 61(2):156-164.
13. Pereira S., Marliss E.B., Morais J.A., Chevalier S., Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes Jan 2008, 57(1):56-63.
14. Baracos V.E. Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies. Cancer Sep 15 2001, 92(Suppl. 6):1669-1677.
15. Heber D., Chlebowski R.T., Ishibashi D.E., Herrold J.N., Block J.B. Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients. Cancer Res Nov 1982, 42(11):4815-4819.
16. Lundholm K., Bennegard K., Eden E., Svaninger G., Emery P.W., Rennie M.J. Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss. Cancer Res Nov 1982, 42(11):4807-4811.
17. Dworzak F., Ferrari P., Gavazzi C., Maiorana C., Bozzetti F. Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover. Cancer Jan 1 1998, 82(1):42-48.
18. Dillon E.L., Volpi E., Wolfe R.R., Sinha S., Sanford A.P., Arrastia C.D., et al. Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy. Clin Nutr (Edinburgh, Scotland) Dec 2007, 26(6):736-743.
19. Emery P.W., Edwards R.H., Rennie M.J., Souhami R.L., Halliday D. Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J (Clin Res Ed) Sep 8 1984, 289(6445):584-586.
20. Melville S., McNurlan M.A., Calder A.G., Garlick P.J. Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer. Cancer Res Feb 15 1990, 50(4):1125-1131.
21. Kimball S.R., Jefferson L.S. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr Jan 2006, 136(1):227S-231S.
22. Tappy L., Acheson K., Normand S., Schneeberger D., Thelin A., Pachiaudi C., et al. Effects of infused amino acids on glucose production and utilization in healthy human subjects. Am J Physiol Jun 1992, 262(6 Pt 1):E826-E833.
23. Krebs M., Krssak M., Bernroider E., Anderwald C., Brehm A., Meyerspeer M., et al. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes Mar 2002, 51(3):599-605.
24. Boden G., Tappy L. Effects of amino acids on glucose disposal. Diabetes Sep 1990, 39(9):1079-1084.
25. Patti M.E., Brambilla E., Luzi L., Landaker E.J., Kahn C.R. Bidirectional modulation of insulin action by amino acids. J Clin Invest Apr 1 1998, 101(7):1519-1529.
26. Tremblay F., Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem Oct 12 2001, 276(41):38052-38060.
27. Tremblay F., Krebs M., Dombrowski L., Brehm A., Bernroider E., Roth E., et al. Overactivation of s6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes Sep 2005, 54(9):2674-2684.
28. Bassil M., Burgos S., Marliss E.B., Morais J.A., Chevalier S., Gougeon R. Hyperaminoacidaemia at postprandial levels does not modulate glucose metabolism in type 2 diabetes mellitus. Diabetologia Jul 2011, 54(7):1810-1818.
29. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol Dec 1982, 5(6):649-655.
30. Chevalier S., Marliss E.B., Morais J.A., Lamarche M., Gougeon R. The influence of sex on the protein anabolic response to insulin. Metabolism Nov 2005, 54(11):1529-1535.
31. Chiolero A., Faeh D., Paccaud F., Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr Apr 2008, 87(4):801-809.
32. Otten J., Pitzi Hellwig J., Myers L.D. Dietary (DRI) reference intakes: the essential guide to nutrient requirements 2006, The National Academies Press, Washington, DC.
33. Chevalier S., Gougeon R., Kreisman S.H., Cassis C., Morais J.A. The hyperinsulinemic amino acid clamp increases whole-body protein synthesis in young subjects. Metabolism Mar 2004, 53(3):388-396.
34. Washburn R.A., Smith K.W., Jette A.M., Janney C.A. The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol Feb 1993, 46(2):153-162.
35. World Health Organization Physical status: the use and interpretation of anthropometry 1995, Report of a WHO Expert Committee, The Organization, Geneva.
36. Fouladiun M., Korner U., Bosaeus I., Daneryd P., Hyltander A., Lundholm K.G. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-correlations with food intake, metabolism, exercise capacity, and hormones. Cancer May 15 2005, 103(10):2189-2198.
37. Murphy R.A., Mourtzakis M., Chu Q.S., Baracos V.E., Reiman T., Mazurak V.C. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer Feb 15 2011.
38. Finegood D.T., Bergman R.N., Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes Aug 1987, 36(8):914-924.
39. Bradley D.C., Steil G.M., Bergman R.N. Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing. Am J Physiol Jun 1993, 264(6 Pt 1):E902-E911.
40. 3C]leucine. Am J Physiol May 1980, 238(5):E473-E479.
41. Harris J.A., Benedict F.G. A biometric study of human basal metabolism. Proc Natl Acad Sci U S A Dec 1918, 4(12):370-373.
42. Fearon K., Strasser F., Anker S.D., Bosaeus I., Bruera E., Fainsinger R.L., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol May 2011, 12(5):489-495.
43. Evans W.J., Morley J.E., Argiles J., Bales C., Baracos V., Guttridge D., et al. Cachexia: a new definition. Clin Nutr (Edinburgh, Scotland) Aug 19 2008.
44. Yoshikawa T., Noguchi Y., Doi C., Makino T., Nomura K. Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure. Nutrition Jul-Aug 2001, 17(7-8):590-593.
45. Savage D.B., Petersen K.F., Shulman G.I. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension May 2005, 45(5):828-833.
46. Asp M.L., Tian M., Wendel A.A., Belury M.A. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer Feb 1 2010, 126(3):756-763.
47. Katsanos C.S., Kobayashi H., Sheffield-Moore M., Aarsland A., Wolfe R.R. Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr Nov 2005, 82(5):1065-1073.
48. Volpi E., Ferrando A.A., Yeckel C.W., Tipton K.D., Wolfe R.R. Exogenous amino acids stimulate net muscle protein synthesis in the elderly. J Clin Invest May 1 1998, 101(9):2000-2007.
49. Volpi E., Kobayashi H., Sheffield-Moore M., Mittendorfer B., Wolfe R.R. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr Aug 2003, 78(2):250-258.
50. Paddon-Jones D., Sheffield-Moore M., Zhang X.J., Volpi E., Wolf S.E., Aarsland A., et al. Amino acid ingestion improves muscle protein synthesis in the young and elderly. Am J Physiol Endocrinol Metab Mar 2004, 286(3):E321-E328.
51. Chevalier S., Goulet E.D., Burgos S.A., Wykes L.J., Morais J.A. Protein anabolic responses to a fed steady state in healthy aging. J Gerontol A Biol Sci Med Sci Jun 2011, 66(6):681-688.
52. Katsanos C.S., Kobayashi H., Sheffield-Moore M., Aarsland A., Wolfe R.R. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab Aug 2006, 291(2):E381-E387.
53. Waterlow J.C. Protein turnover with special reference to man. Q J Exp Physiol Jul 1984, 69(3):409-438.
54. Heslin M.J., Newman E., Wolf R.F., Pisters P.W., Brennan M.F. Effect of systemic hyperinsulinemia in cancer patients. Cancer Res Jul 15 1992, 52(14):3845-3850.
55. Goodpaster B.H., Kelley D.E., Wing R.R., Meier A., Thaete F.L. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes Apr 1999, 48(4):839-847.
56. Murphy R.A., Mourtzakis M., Chu Q.S., Baracos V.E., Reiman T., Mazurak V.C. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer Apr 15 2011, 117(8):1775-1782.
57. Kewalramani G., Bilan P.J., Klip A. Muscle insulin resistance: assault by lipids, cytokines and local macrophages. Curr Opin Clin Nutr Metab Care Jul 2010, 13(4):382-390.
58. Ryden M., Agustsson T., Laurencikiene J., Britton T., Sjolin E., Isaksson B., et al. Lipolysis - not inflammation, cell death, or lipogenesis - is involved in adipose tissue loss in cancer cachexia. Cancer Oct 1 2008, 113(7):1695-1704.
59. Klein S., Wolfe R.R. Whole-body lipolysis and triglyceride-fatty acid cycling in cachectic patients with esophageal cancer. J Clin Invest Nov 1990, 86(5):1403-1408.
60. Agustsson T., Ryden M., Hoffstedt J., van Harmelen V., Dicker A., Laurencikiene J., et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res Jun 1 2007, 67(11):5531-5537.
61. Rofe A.M., Bourgeois C.S., Coyle P., Taylor A., Abdi E.A. Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res Mar-Apr 1994, 14(2B):647-650.
62. Tayek J.A., Manglik S., Abemayor E. Insulin secretion, glucose production, and insulin sensitivity in underweight and normal-weight volunteers, and in underweight and normal-weight cancer patients: a Clinical Research Center study. Metabolism Feb 1997, 46(2):140-145.
63. Byerley L.O., Heber D., Bergman R.N., Dubria M., Chi J. Insulin action and metabolism in patients with head and neck cancer. Cancer Jun 1 1991, 67(11):2900-2906.
64. Adegoke O.A., Chevalier S., Morais J.A., Gougeon R., Kimball S.R., Jefferson L.S., et al. Fed-state clamp stimulates cellular mechanisms of muscle protein anabolism and modulates glucose disposal in normal men. Am J Physiol Endocrinol Metab Jan 2009, 296(1):E105-E113.
65. Floyd J.C., Fajans S.S., Conn J.W., Knopf R.F., Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest Sep 1966, 45(9):1487-1502.
66. Nair K.S., Short K.R. Hormonal and signaling role of branched-chain amino acids. J Nutr Jun 2005, 135(Suppl. 6):1547S-1552S.
67. Barber M.D., Fearon K.C., McMillan D.C., Slater C., Ross J.A., Preston T. Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients. Am J Physiol Endocrinol Metab Sep 2000, 279(3):E707-E714.